What are the recommended daily intakes of omega‑3 (alpha‑linolenic acid, EPA, DHA) and omega‑6 fatty acids for adult men and women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recommended Daily Intakes of Omega Fatty Acids for Adults

For adult men and women, aim for 250 mg/day of combined EPA + DHA as a minimum baseline, with optimal cardiovascular protection achieved at 500 mg/day. 1

Omega-3 Fatty Acids (EPA, DHA, and ALA)

EPA + DHA (Long-Chain Omega-3s)

The most recent comprehensive guideline analysis from 2025 reveals substantial international consensus, though with notable variation:

  • Minimum adequate intake: 250 mg/day EPA + DHA 1

    • This represents the most widely adopted recommendation across 7 international guidelines
    • Supported by European, Norwegian, and multiple national authorities

  • Optimal intake for cardiovascular protection: 500 mg/day EPA + DHA 1

    • Recommended by France, UK, and the International Society for the Study of Fatty Acids and Lipids (ISSFAL)
    • Specifically targets CVD risk reduction
    • France specifies this as 250 mg DHA + 250 mg EPA

  • Gender-specific variations exist but are minimal:

    • Australia/New Zealand set the lowest adequate intake at 90 mg/day for women and 160 mg/day for men (EPA + DPA + DHA combined) 1
    • Korea recommends 150 mg/day for women aged 19-29 years 1

The evidence strongly supports targeting 500 mg/day EPA + DHA rather than settling for the minimum 250 mg/day, as this higher intake provides documented cardiovascular benefits without safety concerns 1.

Alpha-Linolenic Acid (ALA)

  • Recommended intake: 0.8% of total energy intake 1

    • For a 2000 kcal diet, this equals approximately 1.8 g/day
    • For a 2500 kcal diet (typical for men), approximately 2.2 g/day

  • Critical gap: 95% of French adults consume less than 0.5% of energy as ALA, well below recommendations 2

  • Recent data suggests 2.0-2.1 g/day ALA may provide optimal cardiovascular mortality reduction in patients with existing CVD 3

Omega-6 Fatty Acids (Linoleic Acid)

  • Recommended intake: Approximately 12-17 g/day 4
    • 12 g/day for women
    • 17 g/day for men
    • Represents roughly 6% of energy intake

The omega-6 to omega-3 ratio should ideally be 6:1 or lower 5, 6, though the absolute amounts consumed matter more than the ratio itself 5.

Safety Upper Limits

Understanding safe upper limits is crucial for those considering supplementation:

  • Combined EPA + DHA: Up to 5 g/day from supplements poses no safety concerns for adults 1, 7
  • EPA alone: Up to 1.8 g/day is safe 1, 7
  • DHA alone: Up to 1 g/day is safe for the general population 1, 7
  • FDA GRAS status: Up to 3 g/day EPA + DHA from fish oil 1

Practical Implementation

Achieving Targets Through Diet

Most adults fall dramatically short of recommendations 8:

  • U.S. adults average only 23 mg/day EPA and 63 mg/day DHA from food (total 86 mg/day)
  • This is only 17-34% of minimum recommendations

To meet the 500 mg/day EPA + DHA target through food alone:

  • Requires approximately 2-3 servings of oily fish per week 9
  • A single 140g portion of Atlantic mackerel provides sufficient EPA + DHA 9
  • However, 75% of "two portions per week" combinations fail to meet even the lower 250 mg/day target 9

For ALA, efficient sources include 10:

  • Flaxseed oil: 2-3 g/day meets requirements
  • Chia seeds or flaxseeds: 5-7 g/day
  • Walnut, canola, or soybean oils in moderate amounts

When to Consider Supplementation

Supplementation should be considered when:

  • Fish consumption is less than 2-3 servings of oily fish weekly
  • Targeting the optimal 500 mg/day EPA + DHA rather than minimum requirements
  • Vegetarian/vegan diet (focus on ALA-rich sources and consider algae-based EPA/DHA) 1

Supplements are safe and effective 1, 7:

  • Combined EPA + DHA supplements up to 5 g/day show no adverse effects on bleeding risk, glucose homeostasis, or immune function
  • Fish oil and krill oil are both appropriate sources 1

Critical Caveats

  1. Most adults are deficient: Over 50% of populations studied fail to meet even minimum omega-3 recommendations 8, 10

  2. Food sources vary dramatically: Farmed fish still provide adequate EPA + DHA despite higher omega-6 content 9, but crustaceans and mollusks are poor sources (81% and 73% contain <0.01 g/g omega-3) 10

  3. Dose-response is non-linear: Benefits plateau around 2.1 g/day total omega-3 for cardiovascular mortality 3, suggesting diminishing returns beyond optimal intake

  4. Quality control matters: Oxidative stability of omega-3 supplements must be guaranteed to avoid lipid peroxidation 7

  5. Drug interactions: Exercise caution with anticoagulant medications when using high-dose omega-3 supplements 6

References

4
Research

Omega-6 and omega-3 fatty acids: partners in prevention.

Current opinion in clinical nutrition and metabolic care, 2010

Related Questions

In a generally healthy adult without bleeding disorders, is there benefit to omega‑3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)), omega‑6 fatty acids, and omega‑9 fatty acids (oleic acid), and what are the appropriate doses?
How should I dose omega‑3 supplements with capsule strengths of 350 mg, 235 mg, 90 mg, and 597 mg to achieve the recommended daily EPA + DHA intake?
What is the appropriate portion size of fish to obtain adequate omega‑3 fatty acids?
What are the benefits of omega‑3 fatty acid supplementation?
Do I need to eat fish to meet my omega‑3 fatty acid requirements?
What is the most common medication prescribed to hospitalized children and adolescents for sleep?
What are the indications for functional endoscopic sinus surgery (FESS), septoplasty, turbinate reduction (turbinectomy) and polypectomy in chronic sinusitis, and what investigations are needed to determine the need for surgery?
When can glipizide, metformin, and linagliptin (Tradjenta) be restarted after a leadless pacemaker implantation?
In an obese adult with normal vital signs who has dyspnea, hot flashes, and is currently taking sertraline, what evaluation and management steps are recommended?
Do 3‑6‑9 omega supplements provide excess omega‑6 for cardiovascular health benefits?
What are the indications, required investigation findings, and criteria for performing ENT surgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.